SPONSOR
Beijing Tongren Hospital
Total Trials
4
Recruiting
4
Phases
Phase 1, Phase 2
Conditions studied: HNSCCChronic DacryocystitisChildren With MyopiaTreatmentMultizone Lens Design for Myopic DefocusVisual QualityEfficacyDry Eye Disease
Beijing Tongren Hospital is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including HNSCC, Chronic Dacryocystitis, Children With Myopia, Treatment.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Beijing Tongren Hospital
How many clinical trials has Beijing Tongren Hospital sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Beijing Tongren Hospital, of which 4 are actively recruiting participants. These trials cover conditions including HNSCC, Chronic Dacryocystitis, Children With Myopia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Beijing Tongren Hospital research focus on?
Beijing Tongren Hospital clinical trials span HNSCC, Chronic Dacryocystitis, Children With Myopia, Treatment, Multizone Lens Design for Myopic Defocus, and additional conditions. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Beijing Tongren Hospital clinical trial?
To participate in a Beijing Tongren Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Beijing Tongren Hospital trials with current recruitment status updated daily.
Clinical Trials by Beijing Tongren Hospital
NCT07040072 Phase 1
Recruiting
Finotonlimab Combined With Stapokibart in the Treatment of Recurrent/Metastatic HNSCC
HNSCC
NCT07499791 Phase 2
Recruiting
Absorbable Drug-Eluting Lacrimal Sac Stent for Recurrent Chronic Dacryocystitis
Chronic Dacryocystitis
NCT07323251
Recruiting
Clinical Study on the Effectiveness of Diverse Segments Defocus Optimization in Spectacle Lenses for Slowing Myopia Progression
Children With Myopia
NCT06696625
Recruiting
Transcutaneous Auricular Vagus Nerve Stimulation in Dry Eye
Dry Eye Disease
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology